V-Ensure Pharma Technologies Private Limited, a active private limited company, was established on 26 July 2010 in Navi Mumbai, Maharashtra, India. Engaging in api manufacturers within the professional, scientific and technical sector, it holds CIN: U74990MH2010PTC205969. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹6.00 Cr and a paid-up capital of ₹4.11 Cr.
It upholds a compliant status. Its leadership includes Mousumi Satyanarayana Vemula (Director), Sathyanarayana Vemula (Director), Gaurav Sharma (Director). Past directors included Sathyanarayana Vemula, Urmila Devi Vemula, Ashwin Savio Trinidad. It holds ₹81.18 Cr open charges and ₹20.70 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at A-63, Ttc Industrial Area, Midc, Khairane, Navi Mumbai, Maharashtra, 400705.
U74990MH2010PTC205969
205969
26 July 2010
₹6.00 Cr
₹4.11 Cr
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into V-Ensure Pharma Technologies Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Mousumi Satyanarayana Vemula | Director | 26 Jul 2010 | Current |
| Sathyanarayana Vemula | Director | 14 Mar 2020 | Current |
| Gaurav Sharma | Director | 02 Feb 2022 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 06 Apr 2012 | Past |
| Pramod Abcsdd | Director | 14 Mar 2020 | Past |
| Pramod Abcsdd | Cfo | - | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
V-Ensure Pharma Technologies Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 1.95% decrease. The company also saw a substantial fall in profitability, with a 47.26% decrease in profit. The company's net worth moved up by a moderate rise of 2.04%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, V-Ensure Pharma Technologies had a promoter holding of 94.84% and a public holding of 5.15%. The company had 1 Subsidiary. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹811,840,000.00
₹207,000,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 20 Feb 2025 | Others | ₹15.00 Cr | Open |
| 20 Feb 2025 | Others | ₹10.00 Cr | Open |
| 20 Feb 2025 | Others | ₹11.00 Cr | Open |
| 03 Dec 2024 | Hdfc Bank Limited | ₹0.89 M | Open |
| 03 Dec 2024 | Hdfc Bank Limited | ₹0.95 M | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with V-Ensure Pharma Technologies, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of V-Ensure Pharma Technologies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped V-Ensure Pharma Technologies's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity A charge with Others of Rs. 15.00 Cr registered on 20 Feb 2025 with Charge ID 101055058 was modified on 09 Jul 2025. was completed.
Progress on A charge with Others of Rs. 10.00 Cr registered on 20 Feb 2025 with Charge ID 101055051 was modified on 09 Jul 2025. was documented.
The activity A charge with Others of Rs. 11.00 Cr registered on 20 Feb 2025 with Charge ID 101055048 was modified on 09 Jul 2025. was completed.
The activity A charge with Others amounted to Rs. 15.00 Cr with Charge ID 101055058 was registered on 20 Feb 2025. was completed.
Progress on A charge with Others amounted to Rs. 10.00 Cr with Charge ID 101055051 was registered on 20 Feb 2025. was documented.
Progress on A charge with Others amounted to Rs. 11.00 Cr with Charge ID 101055048 was registered on 20 Feb 2025. was documented.
The CIN of V-Ensure Pharma Technologies Private Limited is U74990MH2010PTC205969.
V-Ensure Pharma Technologies Private Limited is headquartered at A-63, Ttc Industrial Area, Midc, Khairane, Navi Mumbai, Maharashtra, 400705.
V-Ensure Pharma Technologies Private Limited was incorporated on 26 July 2010.
The current directors of V-Ensure Pharma Technologies Private Limited are
The primary industry of V-Ensure Pharma Technologies Private Limited is Professional, Scientific And Technical.
V-Ensure Pharma Technologies Private Limited is unlisted.
The authorized capital of V-Ensure Pharma Technologies Private Limited is ₹6.00 Cr, and the paid-up capital is ₹4.11 Cr.
The compliance status of V-Ensure Pharma Technologies Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX